Abstract | OBJECTIVE: METHODS: The anti-Thy-1 MsPGN model was developed by intravenously injecting anti-Thy-1 monoclonal antibodies into rats, followed by an injection of mesangial cells transfected with antisense MCP-1 into the renal artery. Exogenous cells were detected by in situ hybridization. Rats (40 total) were randomly divided into five groups: SO ( sham operation), TG (Thy-1 glomerulonephritis model), MC (non-transfected normal rat mesangial cell), BC (pLXSN empty vector or blank control), and AM (antisense MCP-1 transfection) groups. Effects of exogenous MCP-1 on urinary protein excretion rate, biochemical parameters, and pathological changes were evaluated. Expression of MCP-1 and transforming growth factor-β1 (TGF-β1) were detected by immunohistochemistry. mRNA expression of MCP-1, TGF-β1, and CC chemokine receptor 2 (CCR2) were detected by RT-PCR. RESULTS: Exogenous MCP-1 cDNA was successfully transfected into mesangial cells. Exogenous mesangial cells were detected in glomeruli by in situ hybridization. Glomerular mesangial cell proliferation, 24-h urinary protein excretion rate, mRNA expression of MCP-1, TGF-β1, and CCR2, and protein expression of MCP-1 all decreased in the AM group as compared to the control group (p < 0.05), but there was no significant difference in the expression level of TGF-β1 protein. CONCLUSIONS: (1) Mesangial cells can be used as a vector to transfect exogenous genes into kidneys; (2) antisense MCP-1 decreases mesangial cell proliferation and pathological injury in MsPGN model rats by decreasing expression of MCP-1 and CCR2; and (3) antisense MCP-1 suppressed mesangial cell proliferation and matrix accumulation in anti-Thy-1 MsPGN model rats, which did not entirely depend on TGF-β1.
|
Authors | Hua Liu, Xin-Ping Zhang, Zhu-Wen Yi |
Journal | Renal failure
(Ren Fail)
Vol. 35
Issue 10
Pg. 1418-28
( 2013)
ISSN: 1525-6049 [Electronic] England |
PMID | 23991758
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ccr2 protein, rat
- Chemokine CCL2
- DNA, Antisense
- Isoantibodies
- Receptors, CCR2
- Tgfb1 protein, rat
- Transforming Growth Factor beta1
- anti-Thy antibody
|
Topics |
- Animals
- Chemokine CCL2
(antagonists & inhibitors, metabolism)
- DNA, Antisense
(therapeutic use)
- Disease Models, Animal
- Female
- Genetic Therapy
- Glomerulonephritis, Membranoproliferative
(drug therapy)
- Isoantibodies
- Mesangial Cells
(metabolism)
- Proteinuria
(drug therapy)
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Receptors, CCR2
(metabolism)
- Transforming Growth Factor beta1
(metabolism)
|